Celonic AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Celonic AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014285
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Celonic AG (Celonic), a subsidiary of JRS Pharma LP is a biotechnology company that provides contract development manufacturing organization services. The company’s services include development of cell lines and biotechnological production processes, full GMP analytics, and manufacture of active pharmaceutical ingredients and product batches for clinical trials. Its SEFEX is a proprietary, royalty-free host system and a cell line development platform used for the generation of cell lines for new biological entities and biosimilar products. The company operates through its manufacturing facility located in France, Germany and Switzerland. Celonic is headquartered in Basel, Switzerland.

Celonic AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Celonic AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Celonic AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Celonic AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Celonic AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Celonic AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Celonic AG, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Celonic Acquires Bio-Manufacturing Facility from Glycotope 10
Partnerships 11
Heidelberg Pharma Enters into Agreement with Celonic 11
Istituto Biochimico Italiano Giovanni Lorenzini Enters into Agreement with Celonic 12
Protagen Protein Services, Assign International, Aurigon, Celonic and PharmaLex Form Joint Venture 13
Licensing Agreements 14
Trenzyme Enters into Licensing Agreement with Celonic 14
Asset Transactions 15
JRS Rettenmaier Acquires Contract Manufacturing Business Of Celonic 15
Acquisition 16
JRS Rettenmaier Acquires Celonic’s German Arm 16
Celonic AG – Key Competitors 17
Celonic AG – Key Employees 18
Celonic AG – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Recent Developments 20
Strategy And Business Planning 20
Sep 13, 2017: Merck Expands Celonic’s Upstream Capabilities with Mobius Single-use Bioreactors 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Celonic AG, Pharmaceuticals & Healthcare, Key Facts 2
Celonic AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Celonic AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Celonic AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Celonic AG, Deals By Therapy Area, 2011 to YTD 2017 8
Celonic AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Celonic Acquires Bio-Manufacturing Facility from Glycotope 10
Heidelberg Pharma Enters into Agreement with Celonic 11
Istituto Biochimico Italiano Giovanni Lorenzini Enters into Agreement with Celonic 12
Protagen Protein Services, Assign International, Aurigon, Celonic and PharmaLex Form Joint Venture 13
Trenzyme Enters into Licensing Agreement with Celonic 14
JRS Rettenmaier Acquires Contract Manufacturing Business Of Celonic 15
JRS Rettenmaier Acquires Celonic's German Arm 16
Celonic AG, Key Competitors 17
Celonic AG, Key Employees 18
Celonic AG, Joint Venture 19

★海外企業調査レポート[Celonic AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DaVita Inc (DVA):医療機器:M&Aディール及び事業提携情報
    Summary DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). …
  • The Prudential Insurance Company of America:企業のM&A・事業提携・投資動向
    The Prudential Insurance Company of America - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Prudential Insurance Company of America Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Z Energy Ltd
    Z Energy Ltd - Strategy, SWOT and Corporate Finance Report Summary Z Energy Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Duke Energy Florida LLC:企業の戦略的SWOT分析
    Duke Energy Florida LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Vilniaus Degtine AB:戦略・SWOT・企業財務分析
    Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report Summary Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • DaVita Inc (DVA)-製薬・医療分野:企業M&A・提携分析
    Summary DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). …
  • CIncinnati Children’s Hospital Medical Center:企業のM&A・事業提携・投資動向
    CIncinnati Children's Hospital Medical Center - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CIncinnati Children's Hospital Medical Center Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • SK Hand Tool LLC:企業の戦略的SWOT分析
    SK Hand Tool LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • G M Breweries Ltd:企業の戦略・SWOT・財務分析
    G M Breweries Ltd - Strategy, SWOT and Corporate Finance Report Summary G M Breweries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • NVIDIA Corp (NVDA):企業の財務・戦略的SWOT分析
    NVIDIA Corp (NVDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Retractable Technologies Inc (RVP):企業の財務・戦略的SWOT分析
    Summary Retractable Technologies Inc (Retractable Technologies) is a medical equipment provider that manufactures, develops, designs, and markets syringes and other patient safety products. The company’s products include injection devices, VanishPoint products, bold collection sets, blood collection …
  • EQT Corporation:企業の戦略・SWOT・財務情報
    EQT Corporation - Strategy, SWOT and Corporate Finance Report Summary EQT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Vector Group Ltd.:企業の戦略・SWOT・財務情報
    Vector Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Vector Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Boston Children’s Hospital:企業の戦略的SWOT分析
    Boston Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Stille AB (STIL):企業の財務・戦略的SWOT分析
    Stille AB (STIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Och-Ziff Capital Management Group LLC (OZM):企業の財務・戦略的SWOT分析
    Summary Och-Ziff Capital Management Group LLC (Oz Management) is an alternative asset management firm that provides asset management services. The firm’s services portfolio includes portfolio management, private investments, funds management, and equity funds investment and management services. Its …
  • Angelini Group:企業の戦略的SWOT分析
    Angelini Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Central Foods Ltd:企業の戦略・SWOT・財務分析
    Central Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary Central Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Healthscope Ltd:企業の戦略的SWOT分析
    Healthscope Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • SBI Holdings Inc (8473):企業の財務・戦略的SWOT分析
    SBI Holdings Inc (8473) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆